# Analysis of Human miRNA Derived From Bladder Epithelial Cells Infected With Uropathogenic Escherichia coli

**Authors:** Katarina Persson, Isak Demirel, Ignacio Rangel, Robert Kruse

PMC · DOI: 10.1111/apm.70179 · Apmis · 2026-03-03

## TL;DR

This study explores how bladder cells infected with certain types of E. coli release microRNAs that may influence both human and bacterial genes during urinary tract infections.

## Contribution

The study identifies miRNAs released by bladder cells infected with ESBL-producing E. coli and their potential targets in human and bacterial genomes.

## Key findings

- 402 unique miRNAs were identified, with 30 differentially expressed in ESBL019-infected cells.
- Differentially expressed miRNAs target 747 human genes linked to immune and stress pathways.
- Nine miRNAs were predicted to interact with bacterial genes from an ESBL-producing UPEC strain.

## Abstract

MicroRNAs (miRNAs) have been shown to regulate many cellular processes and to play a role in host‐pathogen interactions. However, the role of miRNA in urinary tract infection (UTI) remains unclear. The aim of this study was to analyze and compare miRNAs from supernatants of human bladder epithelial cells infected with ESBL‐producing (ESBL019) and non‐ESBL‐producing (CFT073) uropathogenic 
E. coli
 (UPEC) strains and to identify miRNA target genes in human cells and uropathogenic bacteria. In total, 402 unique miRNAs were found. The statistical analysis showed differential expression of 30 miRNAs from bladder cells stimulated with ESBL019, while stimulation with CFT073 did not show any significantly expressed miRNAs when compared to unstimulated controls. The 30 differentially expressed miRNAs in ESBL019 stimulated cells showed 747 predicted individual human gene targets. KEGG and REACTOME pathways showed enrichments in pathways mainly connected to immune regulation and stress responses. Of the 30 differentially expressed host miRNAs, nine miRNAs were found to interact with predictive targets of the whole genome from the multi‐resistant, ESBL‐producing UPEC strain EC958. This study shows that ESBL019‐infected bladder epithelial cells release miRNAs with predictive targets in both human and bacterial genes, although their role in UTI cross‐species interactions remains to be clarified.

## Linked entities

- **Diseases:** urinary tract infection (MONDO:0005247)
- **Species:** Escherichia coli (taxon 562), Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** MIR155 (microRNA 155) [NCBI Gene 406947] {aka MIRN155, miRNA155, mir-155}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, MIR132 (microRNA 132) [NCBI Gene 406921] {aka MIRN132, miRNA132, mir-132}, MIR146B (microRNA 146b) [NCBI Gene 574447] {aka MIRN146B, miRNA146B, mir-146b}, SH3PXD2A (SH3 and PX domains 2A) [NCBI Gene 9644] {aka FISH, SH3MD1, TKS5}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, MYD88 (MYD88 innate immune signal transduction adaptor) [NCBI Gene 4615] {aka IMD68, MYD88D, WM1}, NECTIN1 (nectin cell adhesion molecule 1) [NCBI Gene 5818] {aka CD111, CLPED1, ED4, HIgR, HV1S, HVEC}, KIF2B (kinesin family member 2B) [NCBI Gene 84643], KIF21B (kinesin family member 21B) [NCBI Gene 23046], TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}
- **Diseases:** inflammatory/autoimmune diseases (MESH:D001327), pyelonephritis (MESH:D011704), metabolic disorders (MESH:D008659), neurodegenerative diseases (MESH:D019636), inflammatory (MESH:D007249), cancer (MESH:D009369), renal damage (MESH:D007674), bacterial (MESH:D001424), Gram-negative bacteria (MESH:D016905), infectious diseases (MESH:D003141), bladder cancer (MESH:D001749), cardiovascular disease (MESH:D002318), infection (MESH:D007239), E. coli  infection (MESH:D004927), UTI (MESH:D014552), cytotoxicity (MESH:D064420)
- **Chemicals:** tetracyclines (MESH:D013754), Gentamicin (MESH:D005839), CaCl2 (MESH:D002122), pyrimidine (MESH:C030986), streptomycin (MESH:D013307), CO2 (MESH:D002245), LPS (MESH:D008070), L-cysteine (MESH:D003545), beta-lactam (MESH:D047090), CTX-M-15 (-), penicillin (MESH:D010406), fluoroquinolones (MESH:D024841)
- **Species:** Salmonella enterica (species) [taxon 28901], Escherichia coli O25b:H4-ST131 (no rank) [taxon 941322], Escherichia coli (E. coli, species) [taxon 562], Mus musculus (house mouse, species) [taxon 10090], Escherichia coli CFT073 (strain) [taxon 199310], Listeria monocytogenes (species) [taxon 1639], Helicobacter pylori (species) [taxon 210], Homo sapiens (human, species) [taxon 9606], Escherichia coli K-12 (strain) [taxon 83333]
- **Cell lines:** EC958 — Homo sapiens (Human), Mucopolysaccharidosis type IVA, Finite cell line (CVCL_9W79), MB49 — Mus musculus (Mouse), Mouse bladder transitional cell carcinoma, Cancer cell line (CVCL_7076), HBLAK — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_JQ59), CFT073 — Homo sapiens (Human), Cystic fibrosis, Transformed cell line (CVCL_9640)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12955519/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12955519/full.md

## References

54 references — full list in the complete paper: https://tomesphere.com/paper/PMC12955519/full.md

---
Source: https://tomesphere.com/paper/PMC12955519